Sustained Therapeutics Inc. — Form D/A
Sustained Therapeutics Inc. of VANCOUVER, A1, a company, filed a Form D amendment with the SEC on 2022-08-25. The offering totals $100K, of which $100K was reported sold. Industry: Other Health Care.
Offering
- Filed: 2022-08-25
- Form: D/A
- Accession: 0001929737-22-000002
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $100K
- Amount sold: $100K
- Minimum investment: $100K
- Investors: 1
- Date of first sale: 2022-05-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-446815
Issuer
- Name: Sustained Therapeutics Inc.
- CIK: 0001929737
- Entity type: Corporation
- Jurisdiction: CANADA (FEDERAL LEVEL)
- Address: 10TH FLOOR, VANCOUVER, A1, V6C 2T5
- Phone: 778-388-3612
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Martin Gleave | Director | Vancouver, A1 |
| Martin Gleave | Executive Officer | Vancouver, A1 |
| Carol Ammon | Director | Vancouver, A1 |
| Dennis Parolin | Director | Vancouver, A1 |
Other filings by this issuer (2)
More